HomeRSLS • NASDAQ
add
ReShape Lifesciences Inc
Previous close
$0.17
Day range
$0.17 - $0.17
Year range
$0.14 - $2.80
Market cap
3.93M USD
Avg Volume
393.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
LKQ
14.88%
1.20%
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.98M | -36.27% |
Operating expense | 3.74M | -45.30% |
Net income | -1.70M | 89.69% |
Net profit margin | -85.67 | 83.82% |
Earnings per share | — | — |
EBITDA | -1.89M | 59.97% |
Effective tax rate | -1.86% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.46M | 15.67% |
Total assets | 10.66M | -4.30% |
Total liabilities | 4.00M | -46.53% |
Total equity | 6.66M | — |
Shares outstanding | 23.46M | — |
Price to book | 0.60 | — |
Return on assets | -51.24% | — |
Return on capital | -92.05% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.70M | 89.69% |
Cash from operations | -2.46M | 13.15% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 5.46M | 755.96% |
Net change in cash | 3.01M | 231.44% |
Free cash flow | -1.65M | -29.53% |
About
Founded
2002
Headquarters
Website
Employees
29